Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association Between Visit-to-Visit Variability in Low-Density Lipoprotein Cholesterol and Plaque Rupture That Leads to Acute Coronary Syndrome.
Nakano S, Otake H, Kawamori H, Toba T, Sugizaki Y, Nagasawa A, Takeshige R, Matsuoka Y, Tanimura K, Takahashi Y, Fukuyama Y, Shite J, Kozuki A, Iwasaki M, Kuroda K, Takaya T, Hirata KI. Nakano S, et al. Among authors: matsuoka y. Circ Rep. 2021 Aug 12;3(9):540-549. doi: 10.1253/circrep.CR-21-0080. eCollection 2021 Sep 10. Circ Rep. 2021. PMID: 34568633 Free PMC article.
Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.
Otake H, Sugizaki Y, Toba T, Nagano Y, Tsukiyama Y, Yanaka KI, Yamamoto H, Nagasawa A, Onishi H, Takeshige R, Nakano S, Matsuoka Y, Tanimura K, Kawamori H, Shinke T, Hirata KI. Otake H, et al. Among authors: matsuoka y. J Cardiol. 2019 Mar;73(3):228-232. doi: 10.1016/j.jjcc.2018.11.012. Epub 2018 Dec 19. J Cardiol. 2019. PMID: 30579806 Free article.
Adding Alirocumab to Rosuvastatin Helps Reduce the Vulnerability of Thin-Cap Fibroatheroma: An ALTAIR Trial Report.
Sugizaki Y, Otake H, Kawamori H, Toba T, Nagano Y, Tsukiyama Y, Yanaka KI, Yamamoto H, Nagasawa A, Onishi H, Takeshige R, Nakano S, Matsuoka Y, Tanimura K, Takahashi Y, Fukuyama Y, Shinke T, Ishida T, Hirata KI. Sugizaki Y, et al. Among authors: matsuoka y. JACC Cardiovasc Imaging. 2020 Jun;13(6):1452-1454. doi: 10.1016/j.jcmg.2020.01.021. Epub 2020 Mar 18. JACC Cardiovasc Imaging. 2020. PMID: 32199850 Free article. Clinical Trial. No abstract available.
Concomitant Use of Rosuvastatin and Eicosapentaenoic Acid Significantly Prevents Native Coronary Atherosclerotic Progression in Patients With In-Stent Neoatherosclerosis.
Sugizaki Y, Otake H, Kuroda K, Kawamori H, Toba T, Nagasawa A, Takeshige R, Nakano S, Matsuoka Y, Tanimura K, Takahashi Y, Fukuyama Y, Hirata KI. Sugizaki Y, et al. Among authors: matsuoka y. Circ J. 2020 Sep 25;84(10):1826-1836. doi: 10.1253/circj.CJ-20-0199. Epub 2020 Aug 5. Circ J. 2020. PMID: 32759543 Free article. Clinical Trial.
Feasibility of morphological assessment of coronary artery calcification with electrocardiography-gated non-contrast computed tomography: a comparative study with optical coherence tomography.
Takahashi Y, Toba T, Otake H, Fukuyama Y, Nakano S, Matsuoka Y, Tanimura K, Izawa Y, Kawamori H, Kono AK, Fujiwara S, Hirata KI. Takahashi Y, et al. Among authors: matsuoka y. Int J Cardiovasc Imaging. 2021 Apr;37(4):1445-1453. doi: 10.1007/s10554-020-02093-z. Epub 2020 Nov 5. Int J Cardiovasc Imaging. 2021. PMID: 33151511
2,109 results